154 related articles for article (PubMed ID: 2415632)
1. Production of monoclonal antibodies against prostatic acid phosphatase by in vitro immunization of human spleen cells.
Yamaura N; Makino M; Walsh LJ; Bruce AW; Choe BK
J Immunol Methods; 1985 Nov; 84(1-2):105-16. PubMed ID: 2415632
[TBL] [Abstract][Full Text] [Related]
2. Monoclonal antibodies to human prostatic acid phosphatase: probes for antigenic study.
Lillehoj HS; Choe BK; Rose NR
Proc Natl Acad Sci U S A; 1982 Aug; 79(16):5061-5. PubMed ID: 6956915
[TBL] [Abstract][Full Text] [Related]
3. The construction and use of a human-mouse myeloma analogue suitable for the routine production of hybridomas secreting human monoclonal antibodies.
Posner MR; Elboim H; Santos D
Hybridoma; 1987 Dec; 6(6):611-25. PubMed ID: 3436625
[TBL] [Abstract][Full Text] [Related]
4. Production of anti-tumor human monoclonal antibodies using different approaches.
Liu H; Xu ZL; Wang Y; Yang L; Feng O; Li Y; Wang YM; Zhang GG
Hum Antibodies Hybridomas; 1993 Jan; 4(1):2-8. PubMed ID: 8381684
[TBL] [Abstract][Full Text] [Related]
5. Pokeweed mitogen-stimulated human lymphocytes fused to LICR-2 (HMY2) generate human-human hybridomas producing monoclonal IgG antibodies reactive to human breast carcinoma and malignant melanoma.
Martin RF; Kisor R; Schroer D; Eichler G; Filaccio ML
Hum Antibodies Hybridomas; 1990; 1(3):154-9. PubMed ID: 2103359
[TBL] [Abstract][Full Text] [Related]
6. Immunization of normal human splenocytes in vitro to produce human monoclonal antibodies to cellular antigens.
Hulette CM; Effros RB; Walford RL
Tissue Antigens; 1987 Jul; 30(1):25-33. PubMed ID: 3672490
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal anti-human prostatic acid phosphatase antibodies.
Lillehoj HS; Choe BK; Rose NR
Mol Immunol; 1982 Sep; 19(9):1199-202. PubMed ID: 6183581
[TBL] [Abstract][Full Text] [Related]
8. Human monoclonal antibody to purified protein derivative of tuberculin produced by hybrids constructed with Epstein-Barr virus-transformed B lymphocytes and mouse myeloma cells.
Garzelli C; Puglisi C; Falcone G
Eur J Immunol; 1986 May; 16(5):584-7. PubMed ID: 3009205
[TBL] [Abstract][Full Text] [Related]
9. Immunochemical characterization of prostatic acid phosphatase with monoclonal antibodies.
Lee CL; Li CY; Jou YH; Murphy GP; Chu TM
Ann N Y Acad Sci; 1982; 390():52-61. PubMed ID: 7046589
[TBL] [Abstract][Full Text] [Related]
10. The efficient production of stable, human monoclonal antibody-secreting hybridomas from EBV-transformed lymphocytes using the mouse myeloma X63-Ag8.653 as a fusion partner.
Thompson KM; Hough DW; Maddison PJ; Melamed MD; Hughes-Jones N
J Immunol Methods; 1986 Nov; 94(1-2):7-12. PubMed ID: 3023493
[TBL] [Abstract][Full Text] [Related]
11. Production of monoclonal antibodies against calmodulin by in vitro immunization of spleen cells.
Pardue RL; Brady RC; Perry GW; Dedman JR
J Cell Biol; 1983 Apr; 96(4):1149-54. PubMed ID: 6833395
[TBL] [Abstract][Full Text] [Related]
12. SPAM-8, a mouse-human heteromyeloma fusion partner in the production of human monoclonal antibodies. Establishment of a human monoclonal antibody against cytomegalovirus.
Gustafsson B; Jondal M; Sundqvist VA
Hum Antibodies Hybridomas; 1991 Jan; 2(1):26-32. PubMed ID: 1651784
[TBL] [Abstract][Full Text] [Related]
13. Construction and testing of mouse--human heteromyelomas for human monoclonal antibody production.
Teng NN; Lam KS; Calvo Riera F; Kaplan HS
Proc Natl Acad Sci U S A; 1983 Dec; 80(23):7308-12. PubMed ID: 6316357
[TBL] [Abstract][Full Text] [Related]
14. Generation of human monoclonal antibodies against colon cancer.
Koda K; Glassy MC; Chang HR
Arch Surg; 1990 Dec; 125(12):1591-7. PubMed ID: 2244813
[TBL] [Abstract][Full Text] [Related]
15. Influence of antigen presentation and exogenous cytokine activity during in vitro primary immunizations employed for the generation of monoclonal antibodies.
Halabi G; McCullough KC
J Immunol Methods; 1995 Oct; 186(2):205-16. PubMed ID: 7594620
[TBL] [Abstract][Full Text] [Related]
16. Electric field-induced cell fusion and human monoclonal antibodies.
Foung SK; Perkins S
J Immunol Methods; 1989 Jan; 116(1):117-22. PubMed ID: 2536773
[TBL] [Abstract][Full Text] [Related]
17. Characterization of stable Epstein-Barr (EB) virus transformed cell lines and mouse-human hybridomas producing a large quantity of anti-tetanus toxoid (TT) monoclonal antibody.
Minakawa H; Hirata Y; Sugawara I; Fukuda A; Yoshida TO
Behring Inst Mitt; 1985 Dec; (78):139-47. PubMed ID: 3008706
[TBL] [Abstract][Full Text] [Related]
18. Rescue of human monoclonal antibody production from an EBV-transformed B cell line by fusion to a human-mouse hybridoma.
Foung SK; Perkins S; Raubitschek A; Larrick J; Lizak G; Fishwild D; Engleman EG; Grumet FC
J Immunol Methods; 1984 May; 70(1):83-90. PubMed ID: 6201562
[TBL] [Abstract][Full Text] [Related]
19. Reproducible production of protective human monoclonal antibodies by fusion of peripheral blood lymphocytes with a mouse myeloma cell line.
Gigliotti F; Smith L; Insel RA
J Infect Dis; 1984 Jan; 149(1):43-7. PubMed ID: 6607295
[TBL] [Abstract][Full Text] [Related]
20. Generation of human monoclonal antibodies to cancer-associated antigens using limited numbers of patient lymphocytes.
Smith LH; Yin A; Bieber M; Teng NN
J Immunol Methods; 1987 Dec; 105(2):263-73. PubMed ID: 2826600
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
